J Korean Neurol Assoc.
2019 Nov;37(4):372-375. 10.17340/jkna.2019.4.6.
Cefepime Induced Encephalopathy Mimicking Acute Stroke
- Affiliations
-
- 1Department of Neurology, Chuncheon Sacred Heart Hospital, Hallym University College of Medicine, Chuncheon, Korea. bleulsh@naver.com
- KMID: 2464141
- DOI: http://doi.org/10.17340/jkna.2019.4.6
Abstract
- Cefepime is a fourth-generation cephalosporin, developed in 1994, and is well known for its adverse effects. In 2002, the Food and Drug Administration adjusted the labeling to account for increased risk of seizures, encephalopathy and myoclonus, especially in the setting of renal impairment. Here we present a case of an 86-year-old female, undergoing Cefepime treatment, with encephalopathy mimicking acute stroke.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Cefepime-Induced Reversible Encephalopathy with Triphasic Waves in Patients with Impaired Renal Function
- Cefepime-induced neurotoxicity
- Fully Reversible Contrast-Induced Encephalopathy Mimicking Stroke after Flow Diverter Treatment of Carotid Cave Aneurysm
- Characteristic Neuroimaging Findings in a Patient with Acute Metabolic Encephalopathy, Lactic Acidosis and Stroke-Like Episodes Syndrome Distinguishable from that of Acute Ischemic Stroke
- Neurotoxicity Induced by Cefepime in a Patient with Minimal Change Disease
